Iwasaki, S., Kozawa, J., Kimura, T., Fukui, K., Iwahashi, H., Imagawa, A., & Shimomura, I. (2017). Insulin degludec is associated with less frequent and milder hypoglycemia in insulin-deficient patients with type 1 diabetes compared with insulin glargine or detemir. Diabetol Int.
Citação norma ChicagoIwasaki, Shingo, Junji Kozawa, Takekazu Kimura, Kenji Fukui, Hiromi Iwahashi, Akihisa Imagawa, and Iichiro Shimomura. "Insulin Degludec Is Associated With Less Frequent and Milder Hypoglycemia in Insulin-deficient Patients With Type 1 Diabetes Compared With Insulin Glargine or Detemir." Diabetol Int 2017.
MLA CitationIwasaki, Shingo, et al. "Insulin Degludec Is Associated With Less Frequent and Milder Hypoglycemia in Insulin-deficient Patients With Type 1 Diabetes Compared With Insulin Glargine or Detemir." Diabetol Int 2017.